A. “Early and Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease/Alzheimer’s Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional),” (PAR-23-081, a reissue of PAR-21-359, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Pilot Studies for the Spectrum of Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional),” (PAR-23-083).
grants.nih.gov/grants/guide/pa-files/PAR-23-081.html
B. “Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed),” (RFA-AG-24-024, National Institute on Aging, application deadline February 3, 2023).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-024.html
C. “Small Grants to Enhance the Use of the All of Us Research Program’s Data (R03 Clinical Trial Not Allowed),” (RFA-PM-23-002, National Institute on Aging, in conjunction with other agencies, application deadline March 1, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Enhancing the Use of the All of Us Research Programs Data (R21 Clinical Trial Not Allowed),” (RFA-PM-23-001).
